Reduction of macular oedema by acetazolamide in patients with chronic iridocyclitis: a randomised prospective crossover study.

Thirty patients with cystoid macular oedema secondary to chronic iridocyclitis were enrolled in a two period, prospective, randomised, double masked, crossover study that compared sustained release acetazolamide (500 mg twice a day) with a placebo to measure the effects on the reduction of cystoid m...

Cijeli opis

Bibliografski detalji

Izdano u:	Br J Ophthalmol
Glavni autori:	Farber, M D, Lam, S, Tessler, H H, Jennings, T J, Cross, A, Rusin, M M
Format:	Artigo
Jezik:	Inglês
Izdano:	BMJ Publishing Group 1994
Teme:	Research Article
Online pristup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC504681/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8110697/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/bjo.78.1.4
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!